EMOCARE software
DeviceUse of the EMOCARE software on the digital device of participant (smartphone, computer, etc.). The participant can activate and deactivate the software whenever he wishes.
NCT Number: NCT06601140
The aim of this clinical investigation is to find out whether the EMOCARE emotional monitoring software provides consistent results compared with the tools available for assessing the emotional state of patients suffering from mild to moderately severe depressive episod. It will also provide information on how patients feel about the use of passive monitoring software (without the active involvement of patient). The main questions it aims to answer are as follows:
Does EMOCARE provide consistent results compared with tools already used in current practice? What are the medical problems encountered by participants when using EMOCARE?
The researchers will compare EMCOCARE to various questionnaires usually used in the management of patients suffering from depression (PHQ-9, MADRS, GAD-7, BDI-II, EQ-5D-5L).
Participants who agree to take part in the study, during a selection visit, will be able to:
1. Install the software on a digital interface (smartphone, computer, etc.) and activate or deactivate it whenever they wish during the 6-week follow-up period. 2. Attend 2 scheduled appointments at the centre (a first appointment then a second 6 weeks later) to complete a series of questionnaires, being questioned by the doctor, and fill in other questionnaires on their own. 3. At home, answer questionnaires independently, 2 weeks and 4 weeks after the first appointment. 4. Receive a telephone call from the doctor 3 weeks after the first appointment to find out how the participants are feeling. 5. Keep a diary with the symptoms they have experienced, any medical consultations they have made, or changes in drug treatment.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Private psychiatric practice, Agen, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of the EMOCARE software on the digital device of participant (smartphone, computer, etc.). The participant can activate and deactivate the software whenever he wishes.
Time frame: From baseline to 6 weeks
Absolute difference
Time frame: From baseline to 6 weeks
Absolute difference
Time frame: At baseline, at 2 weeks, at 4 weeks
Time frame: From baseline to 2 weeks, from baseline to 4 weeks
Time frame: At baseline, at 2 weeks, at 4 weeks, at 6 weeks
Time frame: From baseline to 2 weeks, From baseline to 4 weeks
Time frame: At baseline, at 6 weeks
Time frame: From baseline to 6 weeks
Time frame: At baseline, at 6 weeks
Time frame: From baseline to 6 weeks
Time frame: At baseline, at 6 weeks
Time frame: From baseline to 6 weeks
Time frame: At baseline, at 2 weeks, at 4 weeks, at 6 weeks
Time frame: From baseline to 2 weeks, from baseline to 4 weeks, from baseline to 6 weeks
Time frame: From baseline to 2 weeks, from baseline to 4 weeks, from baseline to 6 weeks
Time frame: At baseline, at 6 weeks
Time frame: At baseline, at 2 weeks, at 3 weeks, at 4 weeks, at 6 weeks
Time frame: At baseline, at 6 weeks
Contact information is provided by the study sponsor or research team.
Emobot
Industry
Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode: Prospective, Multicentric, Comparative, Single Blind Clinical Investigation. EMC1 Study
Acronym: EMC1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07610473
Behavior, Behavioral Symptoms
Phoenix, Arizona, United States
View Trial DetailsNCT07105397
Depressive Disorder, Depressive Disorder, Major
Fairfax, Virginia, United States
View Trial DetailsNCT07533773
Depressive Disorder, Depressive Disorder, Major
Hefei, Anhui, China
View Trial DetailsNCT07284667
Depressive Disorder, Depressive Disorder, Major
Birmingham, Alabama, United States
View Trial Details